This development marks a crucial step forward in SMSbiotech's efforts to address this debilitating respiratory condition. The Phase I trial, conducted in Australia, will be the first human trial of ...
Hosted on MSN
Clinical trials can transform health care but Australia's system needs an overhaul, doctors say
Eamon Lynham collapses on the polished wooden floor of the family home he shares with his parents — mum Pam and dad Anthony, a respected surgeon and former politician. Minutes earlier, the 27-year-old ...
Pictured: A 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell together and red shows the cancer ...
The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...
This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...
HOUSTON, TX, October 6, 2025 (EZ Newswire) -- BrYet US, Inc., opens new tab (“BrYet”), a biotechnology innovator developing a drug with the potential to be a first-in-class medicine for metastatic ...
Gain Therapeutics announces Phase 1b clinical trial approval in Australia for GT-02287 to evaluate safety in Parkinson's disease patients. Gain Therapeutics, Inc. has received approval to start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results